New York University School of Medicine
New York, 10016, United States
Location status: Recruiting
NCT Number: NCT03293758
The NYU Human Microbiome Study Cohort is designed to improve understanding of the role of human microbiome in health and disease. This study will serve as a critical NYU biorepository resource for research on human genetics and the microbiome in health and disease
Interested in participating?
Request Info40 year and older
All sexes
Observational
New York, 10016, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 5 Years
sex, race, education, oral health status, lifestyle, medical history, anthropometry, and medication use will be collected using the baseline questionnaire at enrolment. The collected information will provide risk stratification information for statistical control in studies of colorectal tumors and other major chronic diseases.
Time frame: 5 Years
Pairwise alignment and clustering of sequences into operational taxonomic units (OTUs)
Contact information is provided by the study sponsor or research team.
Jiyoung Ahn, PhD
CONTACT
Zelle Halloran
CONTACT
NYU Langone Health
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04912739
Behavior, Cancer
Malmö, Skåne County, Sweden
View Trial DetailsNCT06519292
Arterial Occlusive Diseases, Arterial Thrombosis
Amsterdam, North Holland, Netherlands
View Trial DetailsNCT03987633
Arrhythmias, Cardiac, Arterial Occlusive Diseases
Wolverhampton, West Midlands, United Kingdom
View Trial DetailsNCT06516172
Cancer, Cardiovascular Diseases
Heiligenschwendi, Canton of Bern, Switzerland
View Trial Details